CLINICAL_TRIALS
trial_result
· 2024-10-21
Clinical Trial Update: Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS) [Phase 3]
Summary
Phase 3 trial evaluating the efficacy and safety of glepaglutide for Short Bowel Syndrome has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zealand Pharma | Conditions: Short Bowel Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2024-10-21